APPLICATION SITE STREAKING

This adverse event was reported 13 times

APPLICATION SITE STREAKING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HALOBETASOL PROPIONATE AND TAZAROTENE 1 0.0051
1 DALBAVANCIN 1 0.0010
2 AMINOLEVULINIC ACID HYDROCHLORIDE 1 0.0006
3 NORELGESTROMIN AND ETHINYL ESTRADIOL 1 0.0005
4 LIOTHYRONINE SODIUM 1 0.0001
5 MEMANTINE 1 0.0001
6 ESTRADIOL 5 0.0001
7 RIVASTIGMINE 1 0.0001
8 TESTOSTERONE 1 0.0000
9 PROGESTERONE 1 0.0000
See all drugs enriched for association with APPLICATION SITE STREAKING

APPLICATION SITE STREAKING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cholinesterase Inhibitor [EPC] 1 0.0001
1 Progesterone [EPC] 1 0.0000
2 Androgen [EPC] 1 0.0000
3 Provitamin D2 Compound [EPC] 1 0.0000
4 Estrogen [EPC] 6 0.0000
5 Central Nervous System Stimulant [EPC] 1 0.0000
6 Aldosterone Antagonist [EPC] 1 0.0000
7 Retinoid [EPC] 1 0.0000
8 Progestin [EPC] 1 0.0000
See all drug classes enriched for association with APPLICATION SITE STREAKING